Maxigen Biotech : The Company's 2022 Annual Shareholder's Meeting approved the removal of the Company's new directors and their representatives from non-competition restrictions

Close

Today's Information

Provided by: MAXIGEN BIOTECH INC.
SEQ_NO	3	Date of announcement	2022/06/21	Time of announcement	20:16:38
Subject	The Company's 2022 Annual Shareholder's Meeting approved the removal of the Company's new directors and their representatives from non-competition restrictions
Date of events	2022/06/21	To which item it meets	paragraph 21
Statement	1.Date of the shareholders meeting resolution:2022/06/21 2.Name and title of the director with permission to engage in competitive conduct: (1)TCI CO., Ltd. institutional director representative:Tsong-Jieh Chiou (2)Formosa Biomedical Technology Corp. institutional director representative: Shih-Ming Lai 3.Items of competitive conduct in which the director is permitted to engage: Companies with the same or similar business scope as the Company. 4.Period of permission to engage in the competitive conduct: During the term as a director of the Company. 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act): Resolution was approved after voting. 6.If the permitted competitive conduct belongs to the operator of a mainland China area enterprise, the name and title of the directors (if it is not the operator of a Mainland-area enterprise, please enter "N/A" below):N/A 7.Company name of the mainland China area enterprise and the director's position in the enterprise:N/A 8.Address of the mainland China area enterprise:N/A 9.Operations of the mainland China area enterprise:N/A 10.Impact on the company's finance and business:N/A 11.If the directors have invested in the mainland China area enterprise, the monetary amount of the investment and their shareholding ratio:N/A 12.Any other matters that need to be specified:None